Free Trial

Cullinan Therapeutics (CGEM) SEC Filings & 10K Form

Cullinan Therapeutics logo
$16.12 -1.15 (-6.66%)
(As of 02:27 PM ET)

Recent Cullinan Therapeutics SEC Filings

DateFilerForm TypeView
11/07/2024
4:30 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
6:06 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:18 AM
Cullinan Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
10:18 AM
Cullinan Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
11:48 AM
Cullinan Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G/A
10/22/2024
2:24 PM
BlackRock, Inc. (Filed by)
Cullinan Therapeutics (Subject)
Form SC 13G
10/16/2024
6:17 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
6:13 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
4:30 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:27 PM
Cullinan Therapeutics (Subject)
Michaelson Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
5:00 PM
Cullinan Therapeutics (Issuer)
Thistle Mary (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/08/2024
6:20 AM
Cullinan Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:15 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2024
4:30 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2024
3:19 PM
Cullinan Therapeutics (Subject)
Michaelson Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
6:30 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
6:00 PM
Cullinan Therapeutics (Issuer)
Ryan David P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
6:00 PM
Cullinan Therapeutics (Issuer)
Martin Anne-Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
6:00 PM
Cullinan Therapeutics (Issuer)
Rosenberg Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
6:00 PM
Cullinan Therapeutics (Issuer)
Webster Stephen W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:00 PM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
5:00 PM
Cullinan Therapeutics (Issuer)
Ebeling Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
12:30 PM
BlackRock Inc. (Filed by)
Cullinan Therapeutics (Subject)
Form SC 13G/A
06/04/2024
11:15 PM
Cullinan Therapeutics (Filer)
Form EFFECT
06/03/2024
7:12 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
4:07 PM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
4:40 PM
Cullinan Therapeutics (Issuer)
Meek David D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
4:30 PM
Cullinan Therapeutics (Issuer)
Meek David D. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/16/2024
6:30 AM
Cullinan Therapeutics (Filer)
Form ARS
05/16/2024
5:42 AM
Cullinan Therapeutics (Filer)
Form DEFA14A
05/16/2024
5:40 AM
Cullinan Therapeutics (Filer)
Form DEF 14A
05/08/2024
6:30 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
3:32 PM
Cullinan Therapeutics (Subject)
Michaelson Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/30/2024
7:58 PM
Cullinan Therapeutics (Issuer)
Fenton Mary Kay (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/30/2024
8:02 PM
Cullinan Therapeutics (Issuer)
Fenton Mary Kay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
6:05 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
4:50 PM
Cullinan Therapeutics (Subject)
Flynn James E (Filed by)
Form SC 13G
04/16/2024
6:14 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
7:50 PM
Cullinan Therapeutics (Issuer)
Nguyen Nate (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/14/2024
6:22 AM
Cullinan Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/14/2024
6:27 AM
Cullinan Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
DeFi Coin on Verge of Breakout! (Ad)

Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…

You can get access to the report by clicking here now…
03/14/2024
6:14 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2024
4:00 PM
Cullinan Therapeutics (Issuer)
SUMER JACQUELYN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:00 PM
Cullinan Therapeutics (Issuer)
Trigilio Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:00 PM
Cullinan Therapeutics (Issuer)
Jones Jeffrey Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:00 PM
AHMED NADIM (Reporting)
Cullinan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:00 PM
Cullinan Therapeutics (Issuer)
Savill Corrine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
8:01 PM
Blue Owl Capital Holdings LP (Filed by)
Cullinan Therapeutics (Subject)
Form SC 13G
02/06/2024
9:09 AM
Cullinan Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SC 13G
02/02/2024
8:35 PM
Cullinan Therapeutics (Issuer)
Savill Corrine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
3:43 PM
Cullinan Therapeutics (Subject)
Savill Corrine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2024
6:00 PM
Cullinan Therapeutics (Issuer)
Savill Corrine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
4:25 PM
BlackRock Inc. (Filed by)
Cullinan Therapeutics (Subject)
Form SC 13G
01/29/2024
3:27 PM
Cullinan Therapeutics (Subject)
Savill Corrine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2024
3:18 PM
Cullinan Therapeutics (Subject)
Savill Corrine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:15 PM
Cullinan Therapeutics (Filer)
Form 8-K/A
01/08/2024
8:12 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2023
5:30 PM
AHMED NADIM (Reporting)
Cullinan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
4:30 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
4:30 PM
Cullinan Therapeutics (Issuer)
Trigilio Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
4:30 PM
Cullinan Therapeutics (Issuer)
SUMER JACQUELYN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
4:30 PM
Cullinan Therapeutics (Issuer)
Jones Jeffrey Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
5:00 PM
Cullinan Therapeutics (Issuer)
Trigilio Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
5:00 PM
Cullinan Therapeutics (Issuer)
SUMER JACQUELYN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
5:00 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
5:00 PM
Cullinan Therapeutics (Issuer)
Jones Jeffrey Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
7:00 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
7:00 PM
Cullinan Therapeutics (Issuer)
Trigilio Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CGEM) was last updated on 11/12/2024 by MarketBeat.com Staff
From Our Partners